« Back to Record
Citation APA

Gruppen, M. M., Bouts, A., Jansen-van der Weide, M. C., Merkus, M. M., Zurowska, A., Maternik, M., Massella, L., Emma, F., Niaudet, P., Cornelissen, E., Schurmans, T., Raes, A., van de Walle, J., Van Dyck, M., Gulati, A., Bagga, A., & Davin, J.-C. (2018). A randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome. Kidney international, 93(2), 375-389. doi:10.1016/j.kint.2017.08.011


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/272510

Gruppen, M. M., Bouts, A., Jansen-van der Weide, M. C., Merkus, M. M., Zurowska, A., Maternik, M., Massella, L., Emma, F., Niaudet, P., Cornelissen, E., Schurmans, T., Raes, A., van de Walle, J., Van Dyck, M., Gulati, A., Bagga, A., & Davin, J.-C. (2018). A randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome. Kidney international, 93(2), 375-389. doi:10.1016/j.kint.2017.08.011